BURLINGTON, Mass. – April 5, 2016 – inVentiv Group Holdings, Inc., the parent company of inVentiv Health, Inc., today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission in relation to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
Credit Suisse and Morgan Stanley, along with Goldman, Sachs & Co., Jefferies, Citigroup, BofA Merrill Lynch, Barclays and Wells Fargo Securities will serve as bookrunners for the proposed initial public offering.
This proposed offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to these securities, when available, may be obtained from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, Eleven Madison Avenue, New York, NY 10010, by telephone at 1-800-221-1037 or by email at firstname.lastname@example.org; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.